Fat Free Mass (FFM)
ورودیهای بالینی بیمار
حداقل ۱۰ — حداکثر ۳۰۰ • واحد: kg
حداقل ۱۰ — حداکثر ۸۰ • واحد: kg/m²
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Calculated0–1000
The Fat Free Mass (FFM) calculates calculating the predictive value of fat-free mass from body weight and body mass index (BMI). Key inputs include sex. Scores guide tailoring enteral or parenteral nutrition formulas, electrolyte supplementation, and metabolic monitoring. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Calculates the predictive value of fat-free mass from body weight and body mass index (BMI). Useful for weight-based medication dosing, especially in anesthesia, and helps calculate body composition.
Clinical Indication
The Fat Free Mass (FFM) is indicated for bedside clinical practice to support Calculates the predictive value of fat-free mass from body weight and body mass index (BMI). Useful for weight-based medication dosing, especially in anesthesia, and helps calculate body composition.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Hospitalized patients with acute or chronic malnutrition, indicated for total parenteral nutrition (TPN) or enteral tube feeding. Clinical application is indicated across Clinical nutrition teams, surgical recovery wards, intensive care, and metabolic clinics.
Limitations & Contraindications
Anasarca, severe peripheral edema, or ascites artificially inflates body weight and distorts caloric calculations. Clinical exclusion: Attempts to exclude lipids in cellular membranes.
Clinical Pearls & Action Plan
Cautious progressive refeeding with daily surveillance of serum phosphate, potassium, and magnesium prevents refeeding syndrome.
Male: FFM = (9.27 × 10³ × Body Weight) / (6.68 × 10³ + 216 × BMI), Female: FFM = (9.27 × 10³ × Body Weight) / (8.78 × 10³ + 244 × BMI)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| sex | string | Yes | Patient biological sex |
| body_weight_kg | float | Yes | Body weight in kilograms(kg) |
| bmi | float | Yes | Body Mass Index (BMI)(kg/m²) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–1000 | Calculated | Fat-free mass estimation |
Evidence-Based References (EBM)
- Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrnes NM, Green B. Quantification of lean bodyweight. Clin Pharmacokinet. 2005;44(10):1051-65. doi: 10.2165/00003088-200544100-00004.DOI: 10.2165/00003088-200544100-00004
- La Colla L, Albertin A, La Colla G, Mangano A. Predictive value of the Janmahasatian formula for lean body weight in the dosing of sugammadex in morbidly obese patients. Anaesthesia. 2010 Apr;65(4):445-6. doi: 10.1111/j.1365-2044.2010.06284.x.DOI: 10.1111/j.1365-2044.2010.06284.x
- Green B, Duffull SB. What is the best size descriptor to use for pharmacokinetic studies in the obese? Br J Clin Pharmacol. 2004 Aug;58(2):119-33. doi: 10.1111/j.1365-2125.2004.02157.x.DOI: 10.1111/j.1365-2125.2004.02157.x